HERON THERAPEUTICS, INC. /DE/ (HRTX) Operating cash flow 2016–2025
HERON THERAPEUTICS, INC. /DE/ (HRTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$27.6MFY2025 · since FY2016: -$134.1M → -$27.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$27.6M | -22.5% |
| FY2024 | -$22.5M | +61.7% |
| FY2023 | -$58.8M | +60.0% |
| FY2022 | -$146.9M | +27.8% |
| FY2021 | -$203.4M | -10.0% |
| FY2020 | -$184.8M | -48.4% |
| FY2019 | -$124.6M | +35.0% |
| FY2018 | -$191.8M | -12.6% |
| FY2017 | -$170.3M | -27.0% |
| FY2016 | -$134.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice